| Literature DB >> 28057050 |
C M Zarek1, A K Lindholm-Perry2, L A Kuehn3, H C Freetly3.
Abstract
BACKGROUND: To better understand which genes play a role in cattle feed intake and gain, we evaluated differential expression of genes related to gain and intake in the liver of crossbred beef steers. Based on past transcriptomics studies on cattle liver, we hypothesized that genes related to metabolism regulation and the inflammatory response would be differentially expressed. This study used 16 animals with diverse gain and intake phenotypes to compare transcript abundance after a 78 day ad libitum feed study.Entities:
Keywords: Beef cattle; Cellular transport; Feed efficiency; Immune response; Metabolism; Steers; Transcriptome
Mesh:
Substances:
Year: 2017 PMID: 28057050 PMCID: PMC5217266 DOI: 10.1186/s13104-016-2345-3
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Fig. 1Total dry matter intake and total gain for steers on feed trial (n = 143). The average for gain is represented by the horizontal line and the average for intake is represented by the vertical line. The bivariate mean is the intersection of these lines. Steers chosen for the study are represented by the black data points
Cattle breeds within each phenotypic group
| Breed | High gain–high intake | High gain–low intake | Low gain–low intake | Low gain–high intake |
|---|---|---|---|---|
| Angus | 0.25 | 0.25 | 0.008 | 0.125 |
| Brahman | 0 | 0 | 0 | 0.125 |
| Brangus | 0 | 0.031 | 0 | 0 |
| Braunvieh | 0 | 0 | 0.047 | 0 |
| Brown Swiss | 0 | 0 | 0.188 | 0 |
| Charolais | 0.25 | 0.25 | 0.254 | 0.25 |
| Gelbvieh | 0.125 | 0.242 | 0.004 | 0.063 |
| Hereford | 0 | 0.063 | 0.254 | 0 |
| MarcIIa | 0 | 0.008 | 0 | 0 |
| MarcIIIb | 0 | 0.016 | 0.004 | 0.063 |
| Red Angus | 0 | 0 | 0.086 | 0 |
| Santa Gertrudis | 0 | 0 | 0 | 0.188 |
| Shorthorn | 0 | 0.078 | 0 | 0 |
| Simmental | 0.359 | 0 | 0.156 | 0.188 |
| Unknownc | 0.016 | 0.063 | 0 | 0 |
aMarcII animals are 0.25 Simmental, 0.25 Gelbvieh, 0.25 Hereford, and 0.25 Angus
bMarcIII animals are 0.25 Pinzgauer, 0.25 Red Poll, 0.25 Hereford, and 0.25 Angus
cUnknown animals have breed of unknown origin
Over-represented biological processes identified by PANTHER
| Biological process | GO annotation | Number of genes | Expected number of genes | Nominal P value |
|---|---|---|---|---|
| Transport | GO:0006810 | 61 | 48.86 | 4.06E−02 |
| Ion transport | GO:0006811 | 24 | 14.13 | 9.09E−03 |
| Cation transport | GO:0006812 | 22 | 11.39 | 2.93E−03 |
| Carbohydrate metabolic process | GO:0005975 | 20 | 10.94 | 7.92E−03 |
| Mitosis | GO:0007067 | 13 | 6.79 | 2.09E−02 |
| Polysaccharide metabolic process | GO:0005976 | 11 | 3.5 | 9.62E−04 |
| Nucleobase-containing compound transport | GO:0015931 | 7 | 2.27 | 8.56E−03 |
| Sensory perception | GO:0007600 | 5 | 12.14 | 1.74E−02 |
Over-represented molecular functions identified by PANTHER analysis
| Molecular function | GO annotation | Number of genes | Expected number of genes | Nominal P value |
|---|---|---|---|---|
| Transporter activity | GO:0005215 | 37 | 21.81 | 1.36E−03 |
| Transmembrane transporter activity | GO:0022857 | 34 | 19.81 | 1.76E−03 |
| Cation transmembrane transporter activity | GO:0008324 | 17 | 7.46 | 1.65E−03 |
| Cytoskeletal protein binding | GO:0008092 | 10 | 4.78 | 2.36E−02 |
| Amino acid transmembrane transporter activity | GO:0015171 | 6 | 1.7 | 7.91E−03 |
| Intermediate filament binding | GO:0019215 | 2 | 0.22 | 2.01E−02 |
Top canonical pathways identified by IPA analysis for DE genes
| Pathway | Number of DE genes | Percentage of genes (%)a | Nominal P value |
|---|---|---|---|
| Protein ubiquitination pathway | 15 | 6.4 | 2.42E−03 |
| Selenocysteine biosynthesis II (Archaea and Eukaryotes) | 2 | 33.3 | 1.07E−02 |
| Chemokine signaling | 5 | 8.1 | 2.86E−02 |
aThe percent of DE genes in the pathway in relation to the total number of genes in that pathway is given
DE genes identified by IPA
| Pathway | Gene symbol | Gene name | Nominal P value |
|---|---|---|---|
| Proteasome ubiquitination |
| DnaJ heat shock protein family (Hsp40) Member C22 | 5.12E−03 |
|
| DnaJ heat shock protein family (Hsp40) Member C5 | 2.06E−02 | |
|
| DnaJ heat shock protein family (Hsp40) Member B2 | 3.50E−02 | |
|
| DnaJ heat shock protein family (Hsp40) Member C16 | 3.78E−02 | |
|
| Transporter associated with antigen processing 2 | 5.39E−03 | |
|
| Ubiquitin specific peptidase 40 | 9.94E−03 | |
|
| Ubiquitin specific peptidase 26 | 4.55E−02 | |
|
| Ubiquitin C-terminal hydrolase L1 | 3.40E−02 | |
|
| S-phase kinase-associated protein 1 | 1.39E−02 | |
|
| Ubiquitin specific peptidase 14 | 3.97E−02 | |
|
| Ubiquitin specific peptidase 44 | 2.82E−02 | |
|
| Proteasome 26S subunit, ATPase 5 | 4.77E−02 | |
|
| Proteasome subunit alpha 5 | 3.74E−02 | |
|
| Proteasome 26S subunit, non-ATPase 5 | 3.11E−02 | |
|
| SMAD specific E3 ubiquitin protein ligase 1 | 3.28E−02 | |
| Chemokine signaling |
| Protein tyrosine kinase 2 beta | 2.72E−02 |
|
| Calcium/calmodulin dependent protein kinase ii beta | 3.28E−02 | |
|
| Calcium/calmodulin-dependent protein kinase IV | 3.74E−02 | |
|
| Phospholipase C, gamma 1 | 3.83E−02 | |
|
| Kirsten rat sarcoma viral oncogene homolog | 3.86E−02 | |
| Selenocysteine biosynthesis II |
| Phosphoseryl-TRNA kinase | 4.30E−02 |
|
| Sep (O-phosphoserine) TRNA:Sec (Selenocysteine) TRNA synthase | 3.01E−02 |
Microarray and qRT-PCR expression of genes chosen for validation
| qRT-PCR | Microarray | |||||||
|---|---|---|---|---|---|---|---|---|
| Group Xa | Group Ya | Fold changeb | Nominal P value | Group Xa | Group Ya | Fold changeb | Nominal P value | |
|
| 0.039 | 0.099 | 1.15 | 0.53 | 10.63 | 11.38 | 1.68 | 0.03 |
|
| 0.094 | −0.099 | −1.56 | 0.64 | 8.8 | 8.22 | −1.49 | 0.04 |
|
| −0.32 | −0.019 | 2.00 | 0.008 | 6.75 | 7.47 | 1.65 | 0.02 |
|
| 0.12 | −0.37 | −3.09 | 0.29 | 15.48 | 11.84 | −12.47 | 0.009 |
|
| −0.49 | −0.31 | 1.51 | 0.54 | 10.02 | 10.74 | 1.65 | 0.03 |
|
| 0.67 | 0.26 | −2.57 | 0.59 | 6.21 | 5.77 | −1.36 | 0.008 |
|
| −0.18 | −0.02 | 1.45 | 0.06 | 7.02 | 7.41 | 1.31 | 0.03 |
|
| −0.021 | 0.1 | 1.32 | 0.37 | 10.19 | 10.54 | 1.27 | 0.05 |
|
| 0.054 | −0.16 | −1.64 | 0.18 | 7.05 | 7.67 | 1.54 | 0.03 |
|
| 0.16 | 0.11 | −1.12 | 0.15 | 7.13 | 7.74 | 1.53 | 0.001 |
|
| 0.12 | 0.26 | 1.38 | 0.39 | 9.11 | 10.02 | 1.88 | 0.005 |
|
| −0.18 | 0.09 | 1.86 | 0.09 | 7.54 | 7 | −1.45 | 0.02 |
aFor AGPAT3, DNAJB2, SMAD6, and TAP2, Group X was high gain-low intake and Group Y was low gain-high intake. FABP3, PTK2B, PLK3, and TIGAR had high gain-high intake (Group X) and low gain-high intake (Group Y). IGFPB1, NAT1, and NCAPG had high gain-low intake (Group X) and low gain-low intake (Group Y). PPP1CA had high gain-high intake (Group X) and low gain-low intake (Group Y)
bExpression of Groups X and Y (the groups with the greatest differential expression) were compared to determine fold change for each gene